1 active not recruiting, 1 terminated, 1 withdrawn. 3 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Active not recruiting 1, Terminated 1, Withdrawn 1 |
| Phase 2 | 1 | Terminated 1 |
Follow Atacicept: new trials by email Literature Review of Atacicept trials Research Report on Atacicept
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Atacicept in Subjects With IgA Nephropathy Atacicept, Placebo to match Atacicept - IgA Nephropathy, Berger Disease | Phase 3 | Active not recruiting | Vera Therapeutics, Inc. | 428 | 2023-06-29 | 2026-10-01 |
| Atacicept in Subjects With Active Lupus Nephritis (COMPASS) Atacicept, Placebo - Lupus Nephritis (LN) | Phase 3 | Withdrawn | Vera Therapeutics, Inc. | 2022-11-02 | 2025-05-23 | |
| The Efficacy and Safety of Atacicept in Combination With Mycophenolate Mofetil Used to Treat Lupus Nephritis Atacicept, Mycophenolate mofetil, Placebo - Lupus Nephritis | Phase 2 / Phase 3 | Terminated | EMD Serono | 6 | 2007-12-01 | 2016-03-23 |
Lupus Nephritis (2) · Glomerulonephritis, IGA (1) · Lupus Erythematosus, Systemic (1) · Nephritis (1)
Vera Therapeutics, Inc. (2) · EMD Serono (1)
United States (3) · Czechia (1) · Malaysia (1) · Puerto Rico (1) · Singapore (1) · Spain (1) · Taiwan (1)
Eric Michael, MD (1) · Joanne Curley (1)